---
title: "West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289103190.md"
description: "West Pharmaceutical Services Inc. (WST) stock rose 1.67% to $319.75, outperforming competitors Abbott Laboratories, Becton Dickinson, and Baxter International on a mixed trading day. The S&P 500 gained 0.30%, while the Dow Jones fell 0.16%. WST closed 3.36% below its 52-week high of $330.88. Trading volume was below the 50-day average."
datetime: "2026-06-08T21:04:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289103190.md)
  - [en](https://longbridge.com/en/news/289103190.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289103190.md)
---

# West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) rose 1.67% to $319.75 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.30% to 7,405.73 and the Dow Jones Industrial Average falling 0.16% to 50,786.01.

West Pharmaceutical Services Inc. closed 3.36% short of its 52-week high of $330.88, which the company achieved on May 11th.

The stock outperformed some of its competitors Monday, as Abbott Laboratories (ABT) fell 0.63% to $90.50, Becton Dickinson & Co. (BDX) fell 0.77% to $149.99, and Baxter International Inc. (BAX) fell 0.72% to $19.24.

Trading volume (594,539) remained 262,356 below its 50-day average volume of 856,895.

Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-08-26 1704ET

### Related Stocks

- [WST.US](https://longbridge.com/en/quote/WST.US.md)

## Related News & Research

- [A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Consolidation](https://longbridge.com/en/news/288933254.md)
- [West Pharmaceutical Services' (WST) "Overweight" Rating Reiterated at Stephens](https://longbridge.com/en/news/288428697.md)
- [West Appoints Michel Lagarde to be President and Chief Executive Officer | WST Stock News](https://longbridge.com/en/news/288323873.md)
- [Does Perceived Undervaluation at Baxter (BAX) Recast Its Margin Recovery and Portfolio Optimization Story?](https://longbridge.com/en/news/288966831.md)
- [West Pharma names former Thermo Fisher executive Lagarde as CEO](https://longbridge.com/en/news/288329895.md)